Endoscopy 2005; 37(1): 19-25
DOI: 10.1055/s-2004-826064
State of the Art
© Georg Thieme Verlag KG Stuttgart · New York

Treatment of Oesophagogastric Tumours

A.  I.  Morris1 , P.  Collins2
  • 1National Endoscopy Training Centre
  • 2Dept. of Gastroenterology, Royal Liverpool University Hospital, Liverpool, United Kingdom
Further Information

Publication History

Publication Date:
19 January 2005 (online)

Introduction

Endoscopic therapeutic interventions for oesophagogastric tumours are continuing to evolve. The indications for endoscopic therapy and the devices themselves are continuing to develop. It is important that the feasibility, safety, and efficacy of these strategies should be clearly defined, so that their role in patient management can be established. This article reviews noteworthy literature in this area published between June 2003 and 1 September 2004.

References

  • 1 Ackroyd R, Kelty C J, Brown N J. et al . Eradication of dysplastic Barrett’s oesophagus using photodynamic therapy: long-term follow-up.  Endoscopy. 2003;  35 496-501
  • 2 Hage M, Siersema P D, van Dekken H. et al . 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial.  Gut. 2004;  53 785-790
  • 3 Attwood S E, Lewis C J, Caplin S. et al . Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus.  Clin Gastroenterol Hepatol. 2003;  1 258-263
  • 4 Overholt B F, Panjehpour M, Halberg D L. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results.  Gastrointest Endosc. 2003;  58 183-188
  • 5 Seewald S, Akaraviputh T, Seitz U. et al . Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma.  Gastrointest Endosc. 2003;  57 854-859
  • 6 Pacifico R J, Wang K K, Wongkeesong L M. et al . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus.  Clin Gastroenterol Hepatol. 2003;  1 252-257
  • 7 Shimizu Y, Kato M, Yamamoto J. et al . EMR combined with chemoradiotherapy: a novel treatment for superficial esophageal squamous-cell carcinoma.  Gastrointest Endosc. 2004;  59 199-204
  • 8 Hattori S, Muto M, Ohtsu A. et al . EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.  Gastrointest Endosc. 2003;  58 65-70
  • 9 Homs M Y, Hansen B E, van Blankenstein M. et al . Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma.  Eur J Gastroenterol Hepatol. 2004;  16 163-170
  • 10 May A, Gossner L, Behrens A. et al . A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus.  Gastrointest Endosc. 2003;  58 167-175
  • 11 Fujishiro M, Yahagi N, Kashimura K. et al . Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection.  Endoscopy. 2004;  36 579-583
  • 12 Park Y S, Park S W, Kim T I. et al . Endoscopic enucleation of upper-GI submucosal tumors by using an insulated-tip electrosurgical knife.  Gastrointest Endosc. 2004;  59 409-415
  • 13 Ortner M A, Taha A A, Schreiber S. et al . Endoscopic injection of mitomycin adsorbed on carbon particles for advanced esophageal cancer: a pilot study.  Endoscopy. 2004;  36 421-425

A. I. Morris, M. D.

National Endoscopy Training Centre, Royal Liverpool University Hospital

Prescot Street · Liverpool L7 8XP · United Kingdom

Fax: +44-151-706-5832

Email: morris@L18.u-net.com

    >